2005
DOI: 10.1074/jbc.c400534200
|View full text |Cite
|
Sign up to set email alerts
|

A Novel Stress-induced EDEM Variant Regulating Endoplasmic Reticulum-associated Glycoprotein Degradation

Abstract: Proteins expressed in the endoplasmic reticulum (ER) are subjected to a tight quality control. Persistent association with ER-resident molecular chaperones prevents exit of misfolded or incompletely assembled polypeptides from the ER and forward transport along the secretory line. ER-associated degradation (ERAD) is in place to avoid ER constipation. Folding-incompetent products have to be identified to interrupt futile folding attempts and then targeted for unfolding and dislocation into the cytosol for prote… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

2
144
0

Year Published

2006
2006
2014
2014

Publication Types

Select...
4
4

Relationship

0
8

Authors

Journals

citations
Cited by 148 publications
(146 citation statements)
references
References 43 publications
2
144
0
Order By: Relevance
“…EDEM1 presumably possesses mannosidase activity that trims the C branch of N-glycans on misfolded proteins; however, that activity is apparently not required for ERAD acceleration because mutant EDEM1 that lacks the putative active site for mannosidase is still able to accelerate ERAD (Hosokawa et al 2001(Hosokawa et al , 2006(Hosokawa et al , 2010bMolinari et al 2003;Oda et al 2003;Olivari et al 2006). EDEM2 also promotes ERAD, even though it has no enzymatic activity (Mast et al 2005;Olivari et al 2005). In contrast, ERAD-acceleration by EDEM3 (Htm1p/ Mnl1p in yeast) is dependent on its mannosidase activity (Hirao et al 2006;Clerc et al 2009).…”
Section: Recognition and Targetingmentioning
confidence: 99%
“…EDEM1 presumably possesses mannosidase activity that trims the C branch of N-glycans on misfolded proteins; however, that activity is apparently not required for ERAD acceleration because mutant EDEM1 that lacks the putative active site for mannosidase is still able to accelerate ERAD (Hosokawa et al 2001(Hosokawa et al , 2006(Hosokawa et al , 2010bMolinari et al 2003;Oda et al 2003;Olivari et al 2006). EDEM2 also promotes ERAD, even though it has no enzymatic activity (Mast et al 2005;Olivari et al 2005). In contrast, ERAD-acceleration by EDEM3 (Htm1p/ Mnl1p in yeast) is dependent on its mannosidase activity (Hirao et al 2006;Clerc et al 2009).…”
Section: Recognition and Targetingmentioning
confidence: 99%
“…To our surprise, Trichomonas, which makes a Man 5 GlcNAc 2 N-glycan precursor and so was not expected to have N-glycandependent ERAD, contains putative Mns1-like mannosidases, Yos9, and cytosolic PNGases (Figs. 1 E and F and 3B and Table 1) (1)(2)(3)(4)(11)(12)(13)(14)(15)(16)(17)(18)(19)(20)(21)(22)(23)(24)(25)(26).…”
Section: ) (4)mentioning
confidence: 99%
“…One model is that Mns1 removes a single Man residue from the middle arm of Man 9 GlcNAc 2 to make Man 8B GlcNAc 2 , which in turn interacts with EDEM that has chaperone and/or lectin activity. This model is complicated by evidence that Mns1 has weak mannosidase activity in S. pombe (17); more than one Man residue may be removed from N-glycans of misfolded proteins in mammalian cells (13); N-glycan-dependent ERAD occurs in mutant cell lines that are missing the middle and upper Man arms on their N-glycans (18); and there are multiple EDEM paralogs, at least two of which (EDEM1 and EDEM3) have mannosidase activity in vivo (19)(20)(21)(22)(23). Yos9, which resembles the Man-6-P receptor, has also been implicated in N-glycandependent ERAD, likely as a lectin (24,25).…”
mentioning
confidence: 99%
“…The enhanced efficiency of ERAD coincides with the elevated transcription of ER degradation-enhancing mannosidase-like proteins (EDEMs), which are members of the class 47 glycosylhydrolase family (24). Although some EDEM orthologs in lower eukaryotes exhibit mannosidase activity (36), in vitro activity has not been detected for any of the mammalian orthologs (37,38).…”
Section: Checkpoint Activationmentioning
confidence: 99%
“…The intracellular degradation of mammalian glycoproteins, via ERAD, involves the removal of several mannose units by ER mannosidase I (ERManI) and perhaps additional members of the class 47 glycosylhydrolase family, especially in yeast (24)(25)(26)(27)(28). The modified glycans promote extraction of glycoproteins from the calnexin cycle (18), and, in combination with nonnative protein structure, are suspected of completing the formation of a proposed bipartite glycoprotein ERAD (GERAD) signal.…”
Section: Retention and Degradation Of Misfolded Aatmentioning
confidence: 99%